Lilly expects full-year earnings in the range of $22.50 to $24 per share, with revenue in the range of $58 billion to $61 billion. This story was generated by Automated Insights ( ...
Indianapolis Star on MSN11d
How the new $78 million Fever practice facility fits into Indianapolis' plans for downtownFever fans welcome a new $78 million performance facility, one of the first in the WNBA. But others question how the ...
WISH-TV on MSN13d
Deep dive on DeepSeek: Business Insider debriefs DaybreakDeepSeek, a Chinese AI startup, is disrupting the tech world with its high performance at lower prices, affecting Wall Street ...
Sales of Lilly’s top-selling product, the diabetes treatment Mounjaro, jumped 60% to $3.53 billion in the final quarter of ...
This isn't going to look like a brick wall." Indianapolis paid $4 million to ... "So to me, the idea that there is street level engagement with this planned facility, that there is retail ...
it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. INDIANAPOLIS (AP) — Corteva, Inc. CTVA) on Wednesday reported a loss of $41 ...
Just like in 2023 (and almost all years, for that matter), the stock market in 2024 defied the predictions and prognostications of highly paid Wall Street strategists and other soothsayers and ...
The Indianapolis-based company said it had net income of $1.81 per share. Earnings, adjusted for one-time gains and costs, came to $3.84 per share. The results beat Wall Street expectations. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback